Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy

Background: Cardiac resynchronization therapy (CRT) produces acute changes in electric resynchronization that can be measured noninvasively with electrocardiographic body surface mapping (ECGi). The relation between baseline acute electrophysiology metrics and their manipulation with CRT and reverse...

Full description

Bibliographic Details
Main Authors: Thomas Jackson, MBBS, Simon Claridge, PhD, Jonathan Behar, PhD, Cheng Yao, PhD, Mark Elliott, MBBS, Vishal Mehta, MBBS, Justin Gould, PhD, Baldeep Sidhu, MBBS, Helder Pereira, MSc, Steven Niederer, PhD, Gerald Carr-White, PhD, Christopher A. Rinaldi, MD, FHRS
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Heart Rhythm O2
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666501821000064
id doaj-b84897e7d6e04ab2bbe7ff49f0097af5
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Jackson, MBBS
Simon Claridge, PhD
Jonathan Behar, PhD
Cheng Yao, PhD
Mark Elliott, MBBS
Vishal Mehta, MBBS
Justin Gould, PhD
Baldeep Sidhu, MBBS
Helder Pereira, MSc
Steven Niederer, PhD
Gerald Carr-White, PhD
Christopher A. Rinaldi, MD, FHRS
spellingShingle Thomas Jackson, MBBS
Simon Claridge, PhD
Jonathan Behar, PhD
Cheng Yao, PhD
Mark Elliott, MBBS
Vishal Mehta, MBBS
Justin Gould, PhD
Baldeep Sidhu, MBBS
Helder Pereira, MSc
Steven Niederer, PhD
Gerald Carr-White, PhD
Christopher A. Rinaldi, MD, FHRS
Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
Heart Rhythm O2
Body surface mapping
Cardiac resynchronization therapy
ECG imaging
Heart failure
LV activation mapping
author_facet Thomas Jackson, MBBS
Simon Claridge, PhD
Jonathan Behar, PhD
Cheng Yao, PhD
Mark Elliott, MBBS
Vishal Mehta, MBBS
Justin Gould, PhD
Baldeep Sidhu, MBBS
Helder Pereira, MSc
Steven Niederer, PhD
Gerald Carr-White, PhD
Christopher A. Rinaldi, MD, FHRS
author_sort Thomas Jackson, MBBS
title Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
title_short Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
title_full Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
title_fullStr Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
title_full_unstemmed Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
title_sort noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
publisher Elsevier
series Heart Rhythm O2
issn 2666-5018
publishDate 2021-02-01
description Background: Cardiac resynchronization therapy (CRT) produces acute changes in electric resynchronization that can be measured noninvasively with electrocardiographic body surface mapping (ECGi). The relation between baseline acute electrophysiology metrics and their manipulation with CRT and reverse remodeling is unclear. Objective: To test (ECGi) derived parameters of electrical activation as predictors of volumetric response to CRT. Methods: ECGi was performed in 21 patients directly following CRT implant. Activation parameters (left ventricular total activation time [LVtat], global biventricular total activation time [VVtat], global left/right ventricular electrical synchrony [VVsync], and global left ventricular dispersion of activation times [LVdisp]) were measured at baseline and following echocardiographically optimized CRT. Remodeling response (>15% reduction left ventricular end-systolic volume) was assessed 6 months post CRT. Results: Patients were aged 68.9 ± 12.1 years, 81% were male, and 57% were ischemic. Baseline measures of dyssynchrony were more pronounced in left bundle branch block (LBBB) vs non-LBBB. ECGi demonstrated a trend of greater interventricular dyssynchrony between responders and nonresponders that did not reach statistical significance (VVsync: -45.7 ± 22.4 ms vs -25.1 ± 29.3 ms, P = .227). Remaining activation parameters were similar between responders and nonresponders (VVtat 101 ± 22.0 ms vs 98.9 ± 23.4 ms, P = .838; LVtat 86.4 ± 17.1 ms vs 85.1 ± 27.7 ms, P = .904; LVdisp 28.2 ± 6.3 ms vs 27.0 ± 8.7 ms, P = .726). In volumetric responders activation parameters were significantly improved with CRT compared to nonresponders: VV sync (-45.67 ± 22.41 ms vs 2.33±18.87 ms, P = .001), VVtat (101 ± 22.04 ms vs 71 ± 14.01 ms, P = .002), LVtat (86.44 ± 17.15 ms vs 67.67 ± 11.31 ms, P = .006), and LVdisp (28.22 ± 6.3 ms vs 21.56 ± 4.45 ms, P = .008). Conclusion: Baseline ECGi activation times did not predict CRT volumetric response. Volumetric responders exhibited significant improvements in ECGi-derived metrics with CRT. ECGi does not select CRT candidates but may be a useful adjunct to guide left ventricle lead implants and to perform postimplant CRT optimization.
topic Body surface mapping
Cardiac resynchronization therapy
ECG imaging
Heart failure
LV activation mapping
url http://www.sciencedirect.com/science/article/pii/S2666501821000064
work_keys_str_mv AT thomasjacksonmbbs noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT simonclaridgephd noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT jonathanbeharphd noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT chengyaophd noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT markelliottmbbs noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT vishalmehtambbs noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT justingouldphd noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT baldeepsidhumbbs noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT helderpereiramsc noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT stevenniedererphd noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT geraldcarrwhitephd noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
AT christopherarinaldimdfhrs noninvasiveelectrocardiographicassessmentofventricularactivationandremodelingresponsetocardiacresynchronizationtherapy
_version_ 1717817879202627584
spelling doaj-b84897e7d6e04ab2bbe7ff49f0097af52021-09-03T04:47:31ZengElsevierHeart Rhythm O22666-50182021-02-01211218Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapyThomas Jackson, MBBS0Simon Claridge, PhD1Jonathan Behar, PhD2Cheng Yao, PhD3Mark Elliott, MBBS4Vishal Mehta, MBBS5Justin Gould, PhD6Baldeep Sidhu, MBBS7Helder Pereira, MSc8Steven Niederer, PhD9Gerald Carr-White, PhD10Christopher A. Rinaldi, MD, FHRS11School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom; Address reprint requests and correspondence: Dr Thomas Jackson, Department of Cardiology, Salisbury NHS Foundation Trust, Salisbury, Wiltshire SP2 8BJ, UK.School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomMedtronic Ltd./CardioInsight, Cleveland, OhioSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United KingdomMedtronic Ltd./CardioInsight, Cleveland, OhioSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom; Guy’s and St Thomas’ NHS Trust, London, United KingdomBackground: Cardiac resynchronization therapy (CRT) produces acute changes in electric resynchronization that can be measured noninvasively with electrocardiographic body surface mapping (ECGi). The relation between baseline acute electrophysiology metrics and their manipulation with CRT and reverse remodeling is unclear. Objective: To test (ECGi) derived parameters of electrical activation as predictors of volumetric response to CRT. Methods: ECGi was performed in 21 patients directly following CRT implant. Activation parameters (left ventricular total activation time [LVtat], global biventricular total activation time [VVtat], global left/right ventricular electrical synchrony [VVsync], and global left ventricular dispersion of activation times [LVdisp]) were measured at baseline and following echocardiographically optimized CRT. Remodeling response (>15% reduction left ventricular end-systolic volume) was assessed 6 months post CRT. Results: Patients were aged 68.9 ± 12.1 years, 81% were male, and 57% were ischemic. Baseline measures of dyssynchrony were more pronounced in left bundle branch block (LBBB) vs non-LBBB. ECGi demonstrated a trend of greater interventricular dyssynchrony between responders and nonresponders that did not reach statistical significance (VVsync: -45.7 ± 22.4 ms vs -25.1 ± 29.3 ms, P = .227). Remaining activation parameters were similar between responders and nonresponders (VVtat 101 ± 22.0 ms vs 98.9 ± 23.4 ms, P = .838; LVtat 86.4 ± 17.1 ms vs 85.1 ± 27.7 ms, P = .904; LVdisp 28.2 ± 6.3 ms vs 27.0 ± 8.7 ms, P = .726). In volumetric responders activation parameters were significantly improved with CRT compared to nonresponders: VV sync (-45.67 ± 22.41 ms vs 2.33±18.87 ms, P = .001), VVtat (101 ± 22.04 ms vs 71 ± 14.01 ms, P = .002), LVtat (86.44 ± 17.15 ms vs 67.67 ± 11.31 ms, P = .006), and LVdisp (28.22 ± 6.3 ms vs 21.56 ± 4.45 ms, P = .008). Conclusion: Baseline ECGi activation times did not predict CRT volumetric response. Volumetric responders exhibited significant improvements in ECGi-derived metrics with CRT. ECGi does not select CRT candidates but may be a useful adjunct to guide left ventricle lead implants and to perform postimplant CRT optimization.http://www.sciencedirect.com/science/article/pii/S2666501821000064Body surface mappingCardiac resynchronization therapyECG imagingHeart failureLV activation mapping